Incidence of clinical worsening in patients with PAH-CHD in Pulmonary Arterial hyperTENsion sGC-stimulator Trial-2
| Clinical worsening event, n (%)* | Total (n=33) |
|---|---|
| Patients with clinical worsening | 8 (24) |
| Hospitalisation due to PH | 4 (12) |
| Start of new PH treatment | 7 (21) |
| Decrease in 6MWD due to PH | 2 (6) |
| Death | 4 (12) |
*One patient can experience more than one event.
6MWD, 6-min walking distance; CHD, congenital heart disease; PAH, pulmonary atrial hypertension; PH, pulmonary hypertension.